259 related articles for article (PubMed ID: 23458295)
1. The convergence of medicine and neurotoxins: a focus on botulinum toxin type A and its application in aesthetic medicine--a global, evidence-based botulinum toxin consensus education initiative: part II: incorporating botulinum toxin into aesthetic clinical practice.
Carruthers J; Fournier N; Kerscher M; Ruiz-Avila J; Trindade de Almeida AR; Kaeuper G
Dermatol Surg; 2013 Mar; 39(3 Pt 2):510-25. PubMed ID: 23458295
[TBL] [Abstract][Full Text] [Related]
2. The convergence of medicine and neurotoxins: a focus on botulinum toxin type A and its application in aesthetic medicine--a global, evidence-based botulinum toxin consensus education initiative: part I: botulinum toxin in clinical and cosmetic practice.
Carruthers A; Kane MA; Flynn TC; Huang P; Kim SD; Solish N; Kaeuper G
Dermatol Surg; 2013 Mar; 39(3 Pt 2):493-509. PubMed ID: 23458294
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin: examining duration of effect in facial aesthetic applications.
Flynn TC
Am J Clin Dermatol; 2010; 11(3):183-99. PubMed ID: 20369902
[TBL] [Abstract][Full Text] [Related]
4. Botulinum neurotoxin type A-ABO (Dysport): clinical indications and practice guide.
Matarasso A; Shafer D
Aesthet Surg J; 2009 Nov; 29(6 Suppl):S72-9. PubMed ID: 19945008
[TBL] [Abstract][Full Text] [Related]
5. International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)--Part II: Wrinkles on the middle and lower face, neck and chest.
Ascher B; Talarico S; Cassuto D; Escobar S; Hexsel D; Jaén P; Monheit GD; Rzany B; Viel M
J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1285-95. PubMed ID: 20569284
[TBL] [Abstract][Full Text] [Related]
6. Expanding the use of neurotoxins in facial aesthetics: a consensus panel's assessment and recommendations.
Kane M; Donofrio L; Ascher B; Hexsel D; Monheit G; Rzany B; Weiss R
J Drugs Dermatol; 2010 Jan; 9(1 Suppl):s7-22; quiz s23-5. PubMed ID: 20919448
[TBL] [Abstract][Full Text] [Related]
7. International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)--Part I: Upper facial wrinkles.
Ascher B; Talarico S; Cassuto D; Escobar S; Hexsel D; Jaén P; Monheit GD; Rzany B; Viel M
J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1278-84. PubMed ID: 20337830
[TBL] [Abstract][Full Text] [Related]
8. The evolution of botulinum neurotoxin type A for cosmetic applications.
Carruthers J; Carruthers A
J Cosmet Laser Ther; 2007 Sep; 9(3):186-92. PubMed ID: 17763029
[TBL] [Abstract][Full Text] [Related]
9. The science and manufacturing behind botulinum neurotoxin type A-ABO in clinical use.
Wortzman MS; Pickett A
Aesthet Surg J; 2009 Nov; 29(6 Suppl):S34-42. PubMed ID: 19945003
[TBL] [Abstract][Full Text] [Related]
10. Global Aesthetics Consensus: Botulinum Toxin Type A--Evidence-Based Review, Emerging Concepts, and Consensus Recommendations for Aesthetic Use, Including Updates on Complications.
Sundaram H; Signorini M; Liew S; Trindade de Almeida AR; Wu Y; Vieira Braz A; Fagien S; Goodman GJ; Monheit G; Raspaldo H;
Plast Reconstr Surg; 2016 Mar; 137(3):518e-529e. PubMed ID: 26910696
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin in facial rejuvenation: an update.
Carruthers J; Carruthers A
Dermatol Clin; 2009 Oct; 27(4):417-25, v. PubMed ID: 19850191
[TBL] [Abstract][Full Text] [Related]
12. Recommendations for the best possible use of botulinum neurotoxin type a (Speywood units) for aesthetic applications.
Rzany B; Fratila AA; Fischer TC; Hilton S; Pavicic T; Rothhaar A; Sattler G; Sommer B; Pickett A
J Drugs Dermatol; 2013 Jan; 12(1):80-4. PubMed ID: 23377332
[TBL] [Abstract][Full Text] [Related]
13. What are the necessary practice competencies for two providers: dermal fillers and botulinum toxin type A injections?
Spear M
Plast Surg Nurs; 2010; 30(4):226-46; quiz 247-8. PubMed ID: 21217370
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin for cosmetic treatments in young adults: An evidence-based review and survey on current practice among aesthetic practitioners.
Michon A
J Cosmet Dermatol; 2023 Jan; 22(1):128-139. PubMed ID: 36445847
[TBL] [Abstract][Full Text] [Related]
15. Current aesthetic use of abobotulinumtoxinA in clinical practice: an evidence-based consensus review.
Maas C; Kane MA; Bucay VW; Allen S; Applebaum DJ; Baumann L; Cox SE; Few JW; Joseph JH; Lorenc ZP; Moradi A; Nestor MS; Schlessinger J; Wortzman M; Lawrence I; Lin X; Nelson D
Aesthet Surg J; 2012 Sep; 32(1 Suppl):8S-29S. PubMed ID: 22941910
[TBL] [Abstract][Full Text] [Related]
16. [The origin of informed consent].
Mallardi V
Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of type A botulinum toxins for aesthetic indications and their relative economic impact.
Jandhyala R
J Plast Reconstr Aesthet Surg; 2012 Jun; 65(6):720-31. PubMed ID: 22225675
[TBL] [Abstract][Full Text] [Related]
18. Overview of botulinum neurotoxins.
Lowe NJ
J Cosmet Laser Ther; 2007; 9 Suppl 1():11-6. PubMed ID: 17885881
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin type A for aging face and aesthetic uses.
Hexsel C; Hexsel D; Porto MD; Schilling J; Siega C
Dermatol Ther; 2011; 24(1):54-61. PubMed ID: 21276158
[TBL] [Abstract][Full Text] [Related]
20. Cosmetic botulinum toxin: has it replaced more invasive facial procedures?
Loyo M; Kontis TC
Facial Plast Surg Clin North Am; 2013 May; 21(2):285-98. PubMed ID: 23731589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
